Novartis (Sweden)-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2005

  1. Insulin-like growth factor I (IGF-I) replacement therapy increases albumin concentration in liver cirrhosis: Results of a pilot randomized controlled clinical trial

    Journal of Hepatology, Vol. 43, Núm. 4, pp. 630-636